Featured Research

from universities, journals, and other organizations

Important fertility mechanism discovered

Date:
April 24, 2013
Source:
Universität Mainz
Summary:
Scientists have discovered a new mechanism that controls egg cell fertility and that might have future therapeutic potential. They found that the blood protein fetuin-B plays an important and previously unknown role in the fertilization of oocytes. Fetuin-B, first identified in the year 2000, is formed in the liver and secreted into the blood stream.

Oocyte fertilization with and without fetuin-B.
Credit: Walter Stöcker, Institute of Zoology, JGU

Scientists in Mainz and Aachen have discovered a new mechanism that controls egg cell fertility and that might have future therapeutic potential. It was revealed by Professor Dr. Walter Stöcker of the Institute of Zoology at Johannes Gutenberg University Mainz (JGU) that the blood protein fetuin-B plays an important and previously unknown role in the fertilization of oocytes. Fetuin-B, first identified in the year 2000, is formed in the liver and secreted into the blood stream. During a joint research project with researchers at RWTH Aachen University headed by Professor Dr. Willi Jahnen-Dechent of the Helmholtz Institute for Biomedical Engineering, it was discovered that fetuin-B contributes to egg cell fertility by regulating the hardening of the protective zona pellucida of oocytes.

The findings have recently been published in the scientific journal Developmental Cell.

The scientists at Aachen discovered that female mice lacking fetuin-B were infertile even though their ovaries developed normally. But fertility was restored when their ovaries were transplanted in wild-type mice with normal fetuin-B production. "This demonstrates that it was not the ovaries themselves but the plasma protein fetuin-B that determined whether the mice were fertile or not," explained Stöcker.

The role played by the plasma protein fetuin-B was decoded in cooperation with the team in Aachen. The mechanism appears to operate as follows: The oocytes of humans and other mammals are surrounded by a protective envelope called the zona pellucida. This envelope hardens immediately after the successful fertilization of the egg cell by a sperm, which means that subsequent sperm are unable to penetrate the ovum, thus preventing multiple fertilization (polyspermy). Polyspermy results in the death of the embryo in many mammals. The hardening of the zona pellucida is triggered by the proteolytic enzyme ovastacin, the function of which Stöcker's team in Mainz has been investigating. The protease ovastacin is stored in vesicles within the egg cell and when the first sperm penetrates the ovum, the protease is explosively discharged into the gap between the egg cell and the zona pellucida in what is known as the cortical reaction.

However, small amounts of ovastacin continually seep from unfertilized egg cells and this would cause the zona to harden before the first sperm can penetrate. "It is the role of fetuin-B to ensure that these constantly escaping small quantities of ovastacin are inactivated so that oocytes can be fertilized," Stöcker added. "However, once a sperm has penetrated an egg cell, the cortical reaction will be unleashed and the amount of ovastacin will overwhelm the inhibition capacity of fetuin-B and initiate the hardening process."

This is the first time that it has been shown that premature hardening of the zona pellucida can be a cause of infertility. It is thus possible that this could represent the basis for the development of future forms of infertility treatment.


Story Source:

The above story is based on materials provided by Universität Mainz. Note: Materials may be edited for content and length.


Journal Reference:

  1. Eileen Dietzel, Jennifer Wessling, Julia Floehr, Cora Schäfer, Silke Ensslen, Bernd Denecke, Benjamin Rösing, Joseph Neulen, Thomas Veitinger, Marc Spehr, Tanja Tropartz, René Tolba, Thomas Renné, Angela Egert, Hubert Schorle, Yuliya Gottenbusch, André Hildebrand, Irene Yiallouros, Walter Stöcker, Ralf Weiskirchen, Willi Jahnen-Dechent. Fetuin-B, a Liver-Derived Plasma Protein Is Essential for Fertilization. Developmental Cell, 2013; 25 (1): 106 DOI: 10.1016/j.devcel.2013.03.001

Cite This Page:

Universität Mainz. "Important fertility mechanism discovered." ScienceDaily. ScienceDaily, 24 April 2013. <www.sciencedaily.com/releases/2013/04/130424102938.htm>.
Universität Mainz. (2013, April 24). Important fertility mechanism discovered. ScienceDaily. Retrieved September 30, 2014 from www.sciencedaily.com/releases/2013/04/130424102938.htm
Universität Mainz. "Important fertility mechanism discovered." ScienceDaily. www.sciencedaily.com/releases/2013/04/130424102938.htm (accessed September 30, 2014).

Share This



More Health & Medicine News

Tuesday, September 30, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Newsy (Sep. 30, 2014) — The CDC says a new case of Ebola has not been reported in Nigeria for more than 21 days, leading to hopes the outbreak might be nearing its end. Video provided by Newsy
Powered by NewsLook.com
UN Ebola Mission Head: Immediate Action Is Crucial

UN Ebola Mission Head: Immediate Action Is Crucial

AFP (Sep. 30, 2014) — The newly appointed head of the United Nations Mission for Ebola Emergency Response (UNMEER), Anthony Banbury, outlines operations to tackle the virus. Duration: 00:39 Video provided by AFP
Powered by NewsLook.com
CDC Confirms First Case of Ebola in US

CDC Confirms First Case of Ebola in US

AP (Sep. 30, 2014) — The CDC has confirmed the first diagnosed case of Ebola in the United States. The patient is being treated at a Dallas hospital after traveling earlier this month from Liberia. (Sept. 30) Video provided by AP
Powered by NewsLook.com
New Breast Cancer Drug Extends Lives In Clinical Trial

New Breast Cancer Drug Extends Lives In Clinical Trial

Newsy (Sep. 30, 2014) — In a clinical trial, breast cancer patients lived an average of 15 months longer when they received new drug Perjeta along with Herceptin. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins